Bon-Sang Koo

Dr. Bon-Sang Koo


Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
28 May 2021 in Science Advances
Verified
Journal Article
Open access
PDF file
SHSo-Hee Hong
So-Hee Hong
HOHanseul Oh
Hanseul Oh
YPYong Wook Park
Yong Wook Park
HKHye Won Kwak
Hye Won Kwak
EOEun Young Oh
Eun Young Oh
JNJae-Hwan Nam
Jae-Hwan Nam
A previously unknown SARS-CoV-2 vaccine protecting nonhuman primates from SARS-CoV-2 challenge was developed using RBD-P2 and N.

24 March 2021 in Vaccines
Verified
Journal Article
Open access
PDF file
YSYONG BOK SEO
YONG BOK SEO
YSYou Suk Suh
You Suk Suh
JRJi In Ryu
Ji In Ryu
HJHwanhee Jang
Hwanhee Jang
HOHanseul Oh
Hanseul Oh
YSYoung Chul Sung
Young Chul Sung
The unprecedented and rapid spread of SARS-CoV-2 (severe acute respiratory syndrome-coronavirus-2) has motivated the need for a rapidly producible and scalable vaccine. Here, we developed a synthetic soluble SARS-CoV-2 spike (S) DNA-based vaccine candidate, GX-19. In mice, immunization with GX-19 elicited not only S-specific systemic and pulmonary antibody responses but also Th1-biased T cell responses in a dose-dependent manner. GX-19-vaccinated nonhuman primates seroconverted rapidly and exhibited a detectable neutralizing antibody response as well as multifunctional CD4+ and CD8+ T cell responses. Notably, when the immunized nonhuman primates were challenged at 10 weeks after the last vaccination with GX-19, they had reduced viral loads in contrast to non-vaccinated primates as a control. These findings indicate that GX-19 vaccination provides a durable protective immune response and also support further development of GX-19 as a vaccine candidate for SARS-CoV-2.

27 June 2025 in In Vivo
Verified
Journal Article
Open access
Taeho KwonTaeho Kwon
Taeho Kwon
GBGyu-Seo Bae
Gyu-Seo Bae
EJEunsu Jeon
Eunsu Jeon
PKPhilyong Kang
Philyong Kang
HSHee Chang Son
Hee Chang Son
KLKyung-Seob Lim
Kyung-Seob Lim
Porcine/swine viral diseases pose substantial challenges to the global pig industry by affecting animal health and economic stability. This comprehensive review examines four major viral diseases impacting swine populations worldwide: Porcine reproductive and respiratory syndrome (PRRS), African swine fever (ASF), classical swine fever (CSF), and porcine circovirus type 2 (PCV2). We investigated the etiology, epidemiology, clinical signs, and diagnostic methods for each disease, thereby providing an in-depth understanding of their complexities. Additionally, we assessed their global distribution, transmission dynamics, and the economic repercussions they entail. We also discuss current management and control strategies, including vaccination, biosecurity measures, and regulatory policies. Special attention is given to the evolving nature of these diseases, with a focus on emerging strains, new insights into their pathogenesis, and the latest advancements in vaccine development. This review intends to be a valuable resource for veterinarians, researchers, and policymakers, presenting a thorough and current overview of the challenges and developments in managing these swine viral diseases at the international level.

23 October 2019 in Journal of Medical Primatology
Verified
Journal Article
Closed access
PDF file
BKBon-Sang Koo
Bon-Sang Koo
SBSeung Ho Baek
Seung Ho Baek
GKGreen Kim
Green Kim
EHEun‐Ha Hwang
Eun‐Ha Hwang
HOHanseul Oh
Hanseul Oh
JHJUNG JOO HONG
JUNG JOO HONG

1 January 2022 in Immune Network
Verified
Journal Article
Open access
PDF file
SBSeung Ho Baek
Seung Ho Baek
HOHanseul Oh
Hanseul Oh
BKBon-Sang Koo
Bon-Sang Koo
GKGreen Kim
Green Kim
EHEun-Ha Hwang
Eun-Ha Hwang
JHJUNG JOO HONG
JUNG JOO HONG
Baek SH, et al. Immune Netw. 2022 Sep;22(6):e48. https://doi.org/10.4110/in.2022.22.e48

1 January 2019 in Journal of Veterinary Science
Verified
Journal Article
Open access
BKBon-Sang Koo
Bon-Sang Koo
EHEun-Ha Hwang
Eun-Ha Hwang
GKGreen Kim
Green Kim
HOHanseul Oh
Hanseul Oh
YSYeonghoon Son
Yeonghoon Son
JHJUNG JOO HONG
JUNG JOO HONG
Microorganisms play important roles in obesity; however, the role of the gut microbiomes in obesity is controversial because of the inconsistent findings. This study investigated the gut microbiome communities in obese and lean groups of captive healthy cynomolgus monkeys reared under strict identical environmental conditions, including their diet. No significant differences in the relative abundance of Firmicutes, Bacteroidetes and Prevotella were observed between the obese and lean groups, but a significant difference in Spirochetes (p < 0.05) was noted. Microbial diversity and richness were similar, but highly variable results in microbial composition, diversity, and richness were observed in individuals, irrespective of their state of obesity. Distinct clustering between the groups was not observed by principal coordinate analysis using an unweighted pair group method. Higher sharedness values (95.81% ± 2.28% at the genus level, and 79.54% ± 5.88% at the species level) were identified among individual monkeys. This paper reports the association between the gut microbiome and obesity in captive non-human primate models reared under controlled environments. The relative proportion of Firmicutes and Bacteroidetes as well as the microbial diversity known to affect obesity were similar in the obese and lean groups of monkeys reared under identical conditions. Therefore, obesity-associated microbial changes reported previously appear to be associated directly with environmental factors, particularly diet, rather than obesity.